1. FRI0374 Outcomes in Systemic Lupus Erythematosus Patients with High Disease Activity Treated with Belimumab: 18 Month Results from the US Observe Study. (10th June 2014) Authors: Collins, C.E.; Dall'Era, M.; Macahilig, C.; Pappu, R.; Molta, C.; Kan, H.; Koscielny, V. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0261 Outcomes in Systemic Lupus Erythematous (SLE) Patients with High Disease Activity Treated with Belimumab: Results from an Observational Study in the United States (U.S.). (23rd January 2014) Authors: Kan, H.; Collins, C.; Dall'Era, M.; McGuire, M. B.; Koscielny, V.; Pappu, R.; Molta, C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗